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Abstract
Background: The clinical assessment of patients with chest pain of recent onset remains difficult. This study
presents a critical review of clinical predictive tools for the assessment of patients with chest pain.
Methods: Systematic review of observational studies and estimation of probabilities of coronary artery disease
(CAD) in patients with chest pain. Searches were conducted in PubMed, Embase, Scopus, and Web of Science to
identify studies reporting tools, with at least three variables from clinical history, physical examination or ECG,
produced with multivariate analysis, to estimate probabilities of CAD in patients with chest pain of recent onset,
published from inception of the database to the 31st July 2015. The references of previous relevant reviews were
hand searched. The methodological quality was assessed with standard criteria. Since the incidence of CAD has
changed in the past few decades, the date of publication was acknowledged to be relevant in order to use the
tool in clinical practice, and more recent papers were considered more relevant. Probabilities of CAD according to
the studies of highest quality were estimated and the evidence provided was graded.
Results: Twelve papers were included out of the 19126 references initially identified. The methodological quality of
all of them was high. The clinical characteristics of the chest pain, age, past medical history of cardiovascular
disease, gender, and abnormalities in the ECG were the predictors of CAD most commonly reported across the
studies. The most recent papers, with highest methodological quality, and most practical for use in clinical settings,
reported prediction or exclusion of CAD with area under the curve 0.90 in Primary Care, 0.91 in Emergency
department, and 0.79 in Cardiology. These papers provide evidence of high level (1B) and the recommendation to
use their results in the management of patients with chest pain is strong (A).
Conclusions: The risk of CAD can be estimated on clinical grounds in patients with chest pain in different clinical
settings with high accuracy. The estimation of probabilities of CAD presented in these studies could be used for a
better management of patients with chest pain and also in the development of future predictive tools.
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Background
Chest pain of recent onset is a common presenting
symptom. In Primary Care up to 15 % of patients with
chest pain have coronary artery disease (CAD), including
angina pectoris and myocardial infarction, and this pro-
portion increases to 22 % in Emergency departments
and 28 % in Cardiology clinics [1–3]. However, the diag-
nosis of CAD among patients reporting chest pain re-
mains difficult. Nonetheless, despite these acknowledged
difficulties current guidelines state that clinical assessment
alone may be sufficient to confirm or exclude the diagno-
sis of CAD in patients with stable chest pain [4–6]. Clin-
ical history and physical examinations should be the first
step of this clinical assessment and guide further diagnos-
tic tests [4–6]. Many patients referred for further tests are
now offered investigations which have high costs and
some involve exposure to ionising radiation [4, 6]. Both
unnecessary investigations and failure to diagnose CAD
are important issues from a resource and clinical outcome
perspective.
Predictive tools can help clinical decision making. Statis-
tical models can accommodate a large number of factors
and produce consistent results, improving the accuracy of
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clinical judgment, which is not as consistent, especially
with less experienced clinicians [7]. Framingham, QRisk,
and ASSIGN are validated risk predictive tools of cardio-
vascular disease (CVD), widely used in clinical practice, but
they have not been validated in patients presenting with
chest pain [8–10]. The recommendations included in the
NICE guidelines for the clinical estimation of the risk of
CAD in patients with stable chest pain, are based on a sin-
gle study published in 1993 [4, 11]. However, it is acknowl-
edged in the guidelines that this study may overestimate
the risk of CAD in Primary Care, the setting where doctors
usually have to base their decisions purely on the clinical
assessment. More recent studies may also allow a more ac-
curate estimation of the risk of CAD in different settings.
This systematic review aims to identify in the current lit-
erature predictive tools for clinical assessment of patients
with chest pain, in primary and secondary care, and to as-
sess their diagnostic performance. This evidence could in-
form both the management of patients with chest pain
and the development of future diagnostic tools.
Methods
The Meta-analysis Of Observational Studies in Epidemi-
ology (MOOSE) criteria were used to undertake this re-
view (Additional file 1) [12]. Searches were conducted in
PUBMED, EMBASE, SCOPUS and the Web of Science,
from database inception to the 31st of July 2015.
We aimed to identify original studies in compliance
with the following inclusion criteria:
1. Studies including patients with chest pain of recent
onset
2. Studies using diagnosis of CAD as main outcome
3. Multivariate analysis to identify independent
predictors of CAD
4. A predictive tool combining at least three predictors
was derived
5. The predictive tool included variables from the history,
physical examination, or electrocardiogram (ECG)
6. The predictive tool did not include variables from
blood tests, cardiac stress testing, coronary
angiography or coronary scans
7. A computer was not required by the clinician to
estimate risk of CAD with the proposed tool
Studies were excluded if they were limited to specific
patient characteristics (e.g. patients of a specific age
group), or they included mixed exposure or outcome
measures (e.g. chest pain or other symptoms in relation
to CAD and pneumonia), unless separate results for
chest pain and CAD were reported. Studies presenting
computerized clinical decision support were not included
in this review as our objective was to inform the decision
taken by clinicians after clinical assessment, which is
recommended to be the first approach to patients with
chest pain, and the guide of all subsequent management.
In some clinical settings, clinical history and physical
examination may be the only assessment available [4–6].
The search strategy was defined with the help of a med-
ical librarian and is presented in the Additional file 2. The
titles and abstracts identified in the initial search were
checked against inclusion criteria. A number of full text
studies were selected and assessed for inclusion or exclu-
sion. The bibliography of all relevant reviews identified in
the initial search was also checked for further articles
[13–25]. There were no restrictions on the basis of lan-
guage, sample size or duration of follow-up. Relevant data
was extracted from each study using a predefined tem-
plate. Corresponding authors were contacted if any cla-
rification was required. Two reviewers (LA and EG)
independently selected the studies, assessed the quality
and extracted all the data. Any discrepancies were re-
solved by consensus and by a third reviewer (VG).
The quality of the studies was assessed with the
QUADAS tool [26]. Since the prevalence of CAD has
changed in the past few decades the date of publication
was acknowledged to be relevant in order to use the tool
in clinical practice; more recent papers were considered
more relevant [27, 28]. The predictive value of a tool is
different for each clinical setting [29], therefore articles
based in Primary Care, Emergency departments and Car-
diology departments were assessed separately. The results
from the studies were not summarised because it is diffi-
cult to produce sensible summaries using aggregate data
meta-analysis when there are multiple different predictors
used in each paper. The probabilities of CAD in patients
with different clinical presentations, in each clinical set-
ting, were estimated using the tool derived in the studies
considered to be methodologically robust and epidemio-
logically up to date. For the Primary Care and Cardiology
studies [30, 31], the predicted probabilities were calculated
using the formula 1/(1 + e-r) where e is the base of natural
logarithm and r is the linear predictor. For the Emergency
department studies, one paper presented a tool to rule out
CAD, which did not require any calculations [32], and an-
other one presented a formula for calculation [33]. Details
of the calculations are provided in Additional file 3. The
authors of the studies used to calculate probabilities of
CAD were contacted to make sure that a correct inter-
pretation of their tool was being made. The evidence pro-
vided by the papers used to estimate probabilities of CAD
was graded according to the levels of evidence proposed
by the Oxford Centre for Evidence Based Medicine [34].
Results
The initial search produced 19126 references from which
231 full text papers were assessed for inclusion. An add-
itional nine full text studies were also assessed, from the
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593 references of the reviews identified in the initial
search. The first and second reviewer agreed in the inclu-
sion or exclusion of 229 articles and the third reviewer
assessed and decided over the inclusion of the 11
remaining articles. Finally, 12 papers were included in this
review. All papers assessed in full text were in English ex-
cept one, that was in Italian and was assessed by two re-
viewers (EG and VG) with knowledge of that language.
Additional file 4 shows the number of references assessed
at each stage.
Three studies had been conducted in Primary Care,
(Table 1) [30, 35, 36] six in Emergency departments,
(Table 2) [37–40] [32, 33] and four in Cardiology depart-
ments (Table 3) [11, 31, 35, 41]. One study assessed both
patients from Cardiology and Primary Care [35]. The
number of patients in the derivation samples ranged from
284 to 8176 with five studies including over a thousand
patients [11, 30, 31, 35, 41]. All studies were conducted in
the United States or Europe except one that was con-
ducted in Brazil. The quality of the studies was high, with
all of them scoring ≥9 in the 13 items assessment scale
(Additional file 5) [26].
A number of outcomes were reported in different
studies, which included CAD, myocardial infarction
(MI), angina, cardiovascular death, and revascularisation
interventions. Outcomes were defined using combina-
tions of different methods including clinical presenta-
tion, ECG abnormalities, biochemical markers, need for
revascularisation and diagnosis at discharge. The specific
outcome used by each individual study is presented in
Tables 1, 2 and 3. Most studies were conducted during
the clinical management of patients and only one study
clearly reported that the outcome measure was similar for
all patients independently of their initial symptoms [35].
All studies derived the tools using predictors that were
independently associated with the outcome in a multi-
variate regression model. One paper used cox regression,
and reported associations of individual predictors as haz-
ard ratios, and all the other papers used logistic regres-
sion and presented the associations as odd ratios. The
clinical characteristics of the chest pain were associated
with the outcome of 11 studies, five of them specifically
reported exertional pain, and three reported typicality of
chest pain, to be associated with the outcome. Age was
associated with outcome in nine studies. Past medical
history of cardiovascular disease was associated with
outcome in nine studies. Gender in eight studies, abnor-
malities in the ECG in six, and symptoms associated
Table 1 Characteristics of the studies based in Primary Care
Author Country Patients
for score
derivation (n)
Outcome Patients with
outcome n (%)
Maximum
time between
assessment
and outcome
measure
Variables Performance
Soxa 1990
[35]
USA 1074 MI
Angina
Coronary insufficiency
424 (39.5) 1 year Age
Gender
Exertional pain
Patient stops activities
when pain occurs
PMH of MI
Smoking
Pain relived by NTG
For score > 4
S:0.99
Sp:0.18
PPV:0.45
NPV:0.98
Gencer 2010
[36]
Switzerland
Germany
661 CAD 85 (12.9) 1 year Age
Gender
CV Risk Known
Pain location
Pain duration
Exertional pain
Pain on palpation
PMH of CVD
AUC: 0.95 (0.92-0.97)
For scores < 5
(Lowest 5 % for patients
with CAD):S:0.98
Sp:0.71
NPV:0.99
Bösner 2010
[30]
Germany
Switzerland
1199 CAD 180 (15.0) 6 months Age
Gender
Exertional pain
PMH of CVD
Patient assumes pain
of cardiac origin
Pain on palpation
AUC: 0.90 (0.87-0.93)
For a cut-off value of 3
(risk of CAD > 35 %): S:0.86
(0.79-0.92)
Sp:0.75
(0.72-0.78)
PPV:0.35
(0.29-0.41)
NPV:0.97
(0.96-0.98)
MI Myocardial Infarction, PMH Past Medical History, NTG Nitroglycerine, AUC Area Under the Curve, S Sensitivity, Sp Specificity, PPV Positive predictive value, NPV
Negative predictive value
aThis study included both patients from Cardiology and Primary Care
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with chest pain in two studies. However, the description
of clinical symptoms, past medical history of cardiovas-
cular disease, abnormalities of the ECG, and the symp-
toms associated with chest pain, were not recorded
consistently across studies.
The three Primary Care studies reported reclassification
of patients with different clinical presentation against spe-
cified thresholds. Two of them assessed the performance
with measures of discrimination quantified with Area
Under the receiver operating Curve (AUC) as well
[30, 36]. These two studies also reported internal valid-
ation of their diagnostic tool with bootstrapping tech-
niques, and validation in external populations in different
countries, which showed in both cases, results consistent
with the ones obtained in the main analysis [30, 36]. The
study by Bösner et al. was the most recent, had the largest
sample size, presented a clinical tool with the lowest num-
ber of variables, high predictive value, and the most con-
sistent results in the derivation and validation [30]. The
estimation of probabilities of CAD according to the diag-
nostic tool described in this study is presented in Table 4.
This tool provides evidence graded as 1B and recommen-
dation to use it in a Primary Care setting was graded A
(maximum strength).
Five of the six studies conducted in Emergency
departments had MI as an outcome, four of them
had unstable angina as well, and one study used the
probability of not having CAD as an outcome. The
performance of the tool was reported with AUC in five
studies [32, 33, 37, 38, 40], and measures of reclassification
Table 2 Characteristics of the studies based in Emergency departments
Author Country Patients
for score
derivation (n)
Outcome Patients with
outcome n (%)
Maximum time
from assessment
to out come
Variables Performance
Tierney 1985
[37]
USA 284 MI 35 (12.3) 3 months Diaphoresis PMH of MI
ST elevation
Q wave
AUC: 0.85
For patients with
2 factors (risk of
MI > 25 %): S:0.79
Sp:0.89
PPV:0.49
NPV:0.97
Grijeels 1995
[38]
Netherlands 815 MI
Unstable Angina
400 (49.1) At dis-charge Gender
Radiation of pain
Nausea or sweating,
PMH of CVD
Abnormal ECG
AUC: 0.71
Goodacre 2002
[39]
UK 893 MI
Cardiac death
Arrhythmia
Revascularisation
81 (9.1) 1 year Radiation of pain
Burning pain
Nausea/vomiting
Exertional pain
Tender chest wall
Radiation of pain:
PPV:0.14 (0.11-018)
NPV:0.94 (0.91-0.95)
Exertional pain:
PPV: 0.17 (0.12-0.24)
NPV: 0.92 (0.90-0.94)
Bassan 2004
[40]
Brazil 566 MI
Unstable Angina
269 (47.5) Outcome recorded
during acute clinical
management
Age
Chest pain characteristics
PMH of CAD
Diabetes
ST depression,
T wave inversion
AUC: 0.90
(0.88-0.93)
Using cut-off
probability of
CAD 10 %
S: 0.99
Sp:0.41
PPV:0.60
NPV:0.98
Björk 2006
[33]
Sweden 634 MI
Unstable Angina
130 (20.5) Outcome recorded
during acute clinical
management
Age
Hypertension
Angina pectoris
PMH of MI
PMH of CABG
Short symptoms
duration
Abnormal ECG
Derivation cohort
AUC: 88.0
For S 0.95
Sp:0.5
PPV:0.33
NPV:0.98
Sánchez 2007
[32]
Spain 732 Not having CAD 533 (72.8) 1 month Age
Oppressive pain
Pain location
PMH of CAD
Diabetes
AUC: 0.91
(0.89-0.93)
S:0.17
Sp:1
PPV:1
NPV:0.31
CABG Coronary Artery Bypass Graft
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against specified thresholds were also provided in five
studies [32, 33, 37, 39, 40]. Two studies measured the
calibration of their tool with the Hosmer-Lemeshow test.
[32, 37] One paper reported internal validation [33] and
another two reported external validation in different
populations [32, 37].
The study by Sánchez et al. [32] was the most re-
cent one, and presented a tool to triage patients in
the Emergency department and identify those who
don’t need admission into a chest pain unit. In their
observation all the patients in which the following
five features were not present were confirmed not to
have CAD:
– Age over 40
– Previously known CAD
– Diabetes
– Oppressive chest pain
– Retrosternal chest pain.
This model was validated in the same Emergency
department four years later on 4231 patients and again
100 % (n = 231) of patients without any of the five fea-
tures were confirmed not to have CAD [42]. This tool
provides evidence graded as 1B and recommendation to
use it in a clinical setting is of the maximum strength
(grade A).
Another predictive tool, derived in an emergency de-
partment, considered to be methodologically robust and
clinically relevant was developed by Björk et al. [33] It
estimates the probability of CAD using nine variables
providing an AUC 0.88. Björk et al. used a cross valid-
ation procedure and obtained results consistent with the
ones observed in the derivation of the tool. It provides
evidence graded as 1B and recommendation to use it in
a clinical setting is of the maximum strength (grade A).
An estimation of probabilities of CAD based on this tool
is presented in Table 5. The full predictive model is pre-
sented in Additional file 3.
Table 3 Characteristics of the studies based in Cardiology departments
Author Country Patients (n) Out come Patients with
outcome
Maximum
time between
assessment
and outcome
measure
Variables Performance
Soxa 1990 [35] USA 1074 MI
Angina
Coronay
inssufficiency
424 (39.5) 1 year Age
Gender
Exertional pain
Patient stops activities
when pain occurs
PMH of MI
Smoking
Pain relived by NTG
For score > 4
S:0.99
Sp:0.18
PPV:0.45
NPV:0.98
Pryor 1993 [11] USA 168 CAD 109 (64.9) 90 days Age
Gender
Chest pain typicality
PMH of MI
Diabetes
Smoking,
Hyperlipidaemia
ST-T wave changes
Q Waves
AUC:0.87 (0.82-0.93)
Sekhri 2008 [41] UK 8176 CAD 501 (6.1) 4 years Age
Gender
Diabetes
Chest pain typicality
Bundle branch block
Change in ST or
T Q waves
For clinical assessment:
AUC:0.73 (0.71-0.75)
For clinical assessment
+ECG: AUC:0.74 (0.72-0.76)
Genders 2012 [31] USA
Finland
UK
Hungary
Austria
Italy
Russia
Netherlands
Belgium
Germany
Switzerland
5677 CAD 1634 (28.8) Outcome recorded
during acute clinical
management
Age
Gender
Chest pain typicality
Diabetes
Hypertension
Dislipaemia
Smoking
Body Mass Index
AUC:0.79
Net reclassification
compared with model
based only on age
gender and typicality:
35 %
aThis study included both patients from Cardiology and Primary Care
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One paper based in Cardiology department recruited
participants from outpatient rapid access chest pain
clinics [41], another one recruited participants referred
for non invasive testing [11], one from angiography units
[35], and the last one included both patients having CT
coronary angiography and catheter based coronary angi-
ography [31]. The performance of the tool was reported
with AUC in three studies [11, 31, 41]. The study by
Genders et al. [31] was the only one that reported mea-
surements of calibration, together with the measures of
discrimination and reclassification, of its predictive tool.
It was also the most recent and was conducted in 18
hospitals in 11 different countries. It included patients
with symptoms suggestive of stable angina undergoing
angiography. It was also the only study in which the pre-
dictive tool was validated (using cross validation), and
results were consistent with the ones obtained in the
derivation. The estimation of probabilities of CAD
according to the prediction rule described in this study
is presented in Table 6. This tool provides evidence
graded as 1A and recommendation to use it in a clinical
setting of the maximum strength.
Discussion
CAD can be confirmed or ruled out on clinical grounds
in patients with chest pain in Primary Care, Emergency
departments and Cardiology clinics with levels of dis-
crimination up to 91 %, based on AUC. The clinical
characteristics of the chest pain, age, past medical his-
tory of cardiovascular disease, gender, and abnormalities
in the ECG were the predictors of CAD most commonly
reported across the studies.
The comprehensive search and critical assessment of
articles, conducted by three reviewers, following stand-
ard guidelines for reviews of observational research, rep-
resents a strength of this study [12]. It provides strong
evidence of the performance, including discrimination
calibrations and reclassification measures, of the diag-
nostic tools to predict CAD in different clinical settings.
The diversity of the methods used across studies may
Table 4 Probabilities of Coronary Artery Disease (as percentages) in patients with chest pain in Primary Care
Female <65 or Male <55 Female ≥65 or Male ≥55
Known CVD No known CVD Known CVD No known CVD
Pain
reproducible
by palpation
Pain not
reproducible
by palpation
Pain
reproducible
by palpation
Pain not
reproducible
by palpation
Pain
reproducible
by palpation
Pain not
reproducible
by palpation
Pain
reproducible
by palpation
Pain not
reproducible
by palpation
Pain worse
during exercise
Patient attributes
pain to cardiac
origin
21 63 5 24 48 86 15 53
Patient attributes
pain to cardiac
origin
8 34 2 9 23 65 5 26
Pain not worse
during exercise
Patient attributes
pain to cardiac
origin
5 25 1 6 16 55 3 19
Patient attributes
pain to cardiac
origin
2 9 0 2 6 27 1 7
(Based on the tool by Bösner et al.) [30]. CVD: Clinical vascular disease
Note that probabilities are rounded to 0 decimal places, so a probability of 0 % does not imply impossibility
Table 5 Probabilities of Coronary Artery Disease (as percentages) in patients with chest pain in Emergency departments
Age 40 Age 50 Age 60 Age 70
HTN+ HTN- HTN+ HTN- HTN+ HTN- HTN+ HTN-
Symp-toms dura- tion Cd + Cd- Cd+ Cd- Cd+ Cd- Cd+ Cd– Cd+ Cd- Cd+ Cd- Cd+ Cd- Cd+ Cd-
0-6 h AP+ 26 16 13 8 33 22 18 11 42 28 24 15 50 36 31 20
AP- 11 7 5 3 15 9 7 4 20 12 10 6 27 17 14 8
7-12 h AP+ 22 14 11 6 29 18 15 9 36 24 20 12 45 31 26 16
AP- 9 5 4 2 13 7 6 3 17 10 8 5 23 14 11 7
>12 h AP+ 7 4 3 2 10 6 5 3 13 8 6 4 18 11 9 5
AP- 3 1 1 1 4 2 2 1 5 3 2 1 7 4 3 2
(Based on the tool by Björk et al. [33])
Note: Estimations for patients without congestive heart failure, previous myocardial infarction, previous CABG or signs of acute coronary syndrome in the ECG
HTN Hypertension, AP pectoris within previous month, Cd Chest discomfort at arrival to hospital
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have an effect on the external validity of each individual
one.
Previous systematic reviews on the value of the clinical
assessment of patients with suspected CAD have focused
on studies based in Emergency departments [17, 24, 43],
have reported the prognostic value of individual signs
and symptoms [13, 14, 23], or include predictors not
available on clinical history or examination, such as
biomarkers [17, 18]. However, clinicians working in pri-
mary and secondary care base their decisions on combi-
nations of signs and symptoms and in many cases are
not supported by laboratory or radiology tests. The re-
sults of this study complement a review that assessed
scores for CAD that included laboratory tests. They pre-
sented TIMI and GRACE scores, as the most extensively
investigated, with GRACE showing better performance,
Table 6 Probabilities of Coronary Artery Disease (as percentages) in patients with symptoms suggestive of stable angina undergoing
angiography
Female Age 40 Age 50 Age 60 Age 70 Age 80
T A Ns T A Ns T A Ns T A Ns T A Ns
DM+ HTN+ Dislip+ Smk+ 20 8 5 31 15 8 46 24 15 61 37 24 74 53 37
Smk- 13 6 3 22 10 5 35 17 10 50 27 17 65 41 27
Dislip- Smk+ 14 6 3 23 10 6 36 17 10 51 28 17 66 42 28
Smk- 9 4 2 16 7 4 26 12 7 39 20 12 55 31 20
HTN- Dislip+ Smk+ 15 6 3 24 11 6 37 19 11 53 30 18 67 44 30
Smk- 10 4 2 17 7 4 27 13 7 41 21 12 57 33 21
Dislip- Smk+ 10 4 2 17 7 4 28 13 7 42 22 13 58 34 22
Smk- 7 3 1 12 5 3 20 9 5 32 15 9 46 25 15
DM- HTN+ Dislip+ Smk+ 14 4 2 23 7 4 35 12 7 50 21 12 65 33 20
Smk- 9 2 1 16 5 2 26 8 4 39 14 8 54 23 14
Dislip- Smk+ 9 3 1 16 5 3 26 8 5 40 15 8 55 24 14
Smk- 6 2 1 11 3 2 18 5 3 30 10 5 44 17 10
HTN- Dislip+ Smk+ 10 3 2 17 5 3 28 9 5 42 16 9 57 26 15
Smk- 7 2 1 12 3 2 20 6 3 31 10 6 46 18 10
Dislip- Smk+ 7 2 1 12 3 2 20 6 3 32 11 6 47 18 11
Smk- 4 1 1 8 2 1 14 4 2 23 7 4 36 12 7
Male
DM+ HTN+ Dislip+ Smk+ 48 26 16 63 40 26 76 55 39 86 69 55 92 81 69
Smk- 37 18 11 52 29 18 67 43 29 79 59 43 87 73 58
Dislip- Smk+ 38 19 11 53 30 19 68 44 30 80 60 44 88 73 59
Smk- 28 13 7 41 21 13 57 33 21 71 48 33 82 63 48
HTN- Dislip+ Smk+ 40 20 12 55 32 20 69 46 32 81 62 46 89 75 61
Smk- 29 14 8 44 23 14 59 35 22 73 50 35 83 65 50
Dislip- Smk+ 30 14 8 44 23 14 60 36 23 73 51 36 84 66 51
Smk- 21 9 5 34 16 9 48 26 16 64 40 26 76 55 40
DM- HTN+ Dislip+ Smk+ 38 13 8 53 22 13 68 35 22 79 50 34 88 65 49
Smk- 28 9 5 41 15 9 57 25 15 71 38 25 82 54 38
Dislip- Smk+ 28 9 5 42 16 9 58 26 16 72 39 26 82 55 39
Smk- 20 6 3 32 11 6 46 18 10 62 29 18 75 43 29
HTN- Dislip+ Smk+ 30 10 5 44 17 10 60 27 17 73 41 27 84 57 41
Smk- 21 6 4 33 11 6 48 19 11 63 31 19 76 45 30
Dislip- Smk+ 22 7 4 34 12 7 49 20 12 64 32 20 77 46 31
Smk- 15 4 2 25 8 4 38 14 8 53 23 13 68 35 22
(Based on the tool by Genders et al.) [31]
DM Diabetes Mellitus, HTN Hypertension, Dislip Dislipaemia, Smk Smoking (positive if the patient is a current smoker or an ex-smoker), T Typical chest pain, A Atypical
chest pain, Ns Non-specific chest pain
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and reported that there are other potentially useful risk
scores that had not been validated [18].
Future studies may derive diagnostic tool, or validate
[44] the ones presented in this review, in larger datasets
and use more uniform measures for predictors and out-
comes. Ideally the outcome to be used in future studies
should include all clinically relevant cases of CAD rather
than specific ones such as only angina or only MI. The
performance of future predictive tools should also in-
clude measures of discrimination, calibration, which was
only reported in three papers included in this review
[31, 32, 37], and reclassification [45]. Measures of impact,
that is whether the predictive tool is used by physicians,
changes therapeutic decisions, improves the clinical pro-
cess and patient outcome, or reduces costs, should also be
reported [44]. As computers become more available, and
use of software more accepted in clinical settings [46, 47],
further research may also look at computer aided clinical
decision support tools for patients with chest pain of re-
cent onset.
The guidelines from the European Society of Cardi-
ology acknowledges that non-invasive, imaging-based
diagnostic methods for CAD have typical sensitivities
and specificities of approximately 85 %, therefore 15 %
of all diagnostic results will be false. For this reason they
recommend no testing if the probabilities of CAD esti-
mated on clinical grounds are <15 % or >85 %, assuming
that these patients are healthy or have stable CAD
respectively [6]. The NICE, and the American Heart
Association, guidelines use thresholds for further tests
between 10 % and 90 % [4, 5]. Authors of future predict-
ive tools may therefore consider reporting measures of
reclassification against these defined, non arbitrary,
thresholds for clinical intervention [45], which were only
used in one study included this review [40].
Conclusions
The predictors of CAD observed in our review may be
considered by clinicians, and also by researchers in the
development of further diagnostic tools. The estimated
probability of CAD presented in this review can be used
in the assessment of patients with chest pain in primary
care, emergency departments and cardiology clinics.
However, despite the good performance of some of the
predictive tools, none can guarantee a completely accur-
ate diagnosis of CAD, therefore clinical judgement re-
mains an essential element for the clinical decision.
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